ATE365043T1 - Endotoxinhemmern zur behandlung von kachexie - Google Patents
Endotoxinhemmern zur behandlung von kachexieInfo
- Publication number
- ATE365043T1 ATE365043T1 AT00916915T AT00916915T ATE365043T1 AT E365043 T1 ATE365043 T1 AT E365043T1 AT 00916915 T AT00916915 T AT 00916915T AT 00916915 T AT00916915 T AT 00916915T AT E365043 T1 ATE365043 T1 AT E365043T1
- Authority
- AT
- Austria
- Prior art keywords
- lps
- endotoxin
- lipopolysaccharide
- gut
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9905314.2A GB9905314D0 (en) | 1999-03-09 | 1999-03-09 | Therapy and use of compounds in therapy (2) |
GBGB9905307.6A GB9905307D0 (en) | 1999-03-09 | 1999-03-09 | Therapy and use of compounds in therapy |
GBGB9905315.9A GB9905315D0 (en) | 1999-03-09 | 1999-03-09 | Therapy and use of compounds in therapy |
GBGB9905300.1A GB9905300D0 (en) | 1999-03-09 | 1999-03-09 | Therapy and use of agents in therapy |
GBGB9905310.0A GB9905310D0 (en) | 1999-03-09 | 1999-03-09 | Therapy and use of compounds in therapy (4) |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE365043T1 true ATE365043T1 (de) | 2007-07-15 |
Family
ID=27517498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00916915T ATE365043T1 (de) | 1999-03-09 | 2000-03-09 | Endotoxinhemmern zur behandlung von kachexie |
Country Status (10)
Country | Link |
---|---|
US (2) | US20070197485A1 (de) |
EP (2) | EP1212064A2 (de) |
AT (1) | ATE365043T1 (de) |
AU (2) | AU4105600A (de) |
CY (1) | CY1107436T1 (de) |
DE (1) | DE60035262T2 (de) |
DK (1) | DK1158989T3 (de) |
ES (1) | ES2288847T3 (de) |
PT (1) | PT1158989E (de) |
WO (2) | WO2000053165A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1302206A1 (de) * | 2001-10-11 | 2003-04-16 | Universitair Medisch Centrum Utrecht | Verfahren und Mittel zur Verwendung des adventitial Toll-like-Rezeptors |
US20040122067A1 (en) * | 2002-12-20 | 2004-06-24 | Lin Zhao | Treatment of chronic heart failure |
US7655237B2 (en) | 2003-03-21 | 2010-02-02 | Bridge Bioresearch Limited | Use of soluble CD14 for treatment of type 2 diabetes mellitus |
US7883701B2 (en) * | 2003-12-19 | 2011-02-08 | Wisconsin Alumni Research Foundation | Method for enhancing growth or increasing feed efficiency through reducing binding between endotoxin and its receptor in the gastrointestinal tract |
CN1964727A (zh) * | 2004-06-02 | 2007-05-16 | 株式会社吴羽 | 循环器官功能障碍因子除去剂 |
TWI487535B (zh) | 2004-11-30 | 2015-06-11 | Centocor Inc | 類鐸受體3(toll like receptor3)拮抗劑,方法及用途 |
EP1741440A1 (de) * | 2005-07-08 | 2007-01-10 | Mellitus S.L. | Verwendung von BPI-proteine zur Behandlung von stoffwechselbedingten Erkrankungen und Herzkreislaufstörungen |
WO2007051164A2 (en) | 2005-10-27 | 2007-05-03 | Centocor, Inc. | Toll like receptor 3 modulators, methods and uses |
KR100785656B1 (ko) * | 2007-05-14 | 2007-12-17 | 재단법인서울대학교산학협력재단 | 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체 |
EP2208497A1 (de) * | 2009-01-15 | 2010-07-21 | Charité-Universitätsmedizin Berlin (Charité) | Verwendung von Ursodesoxycholsäure (UDCA) zum Verbessern des allgemeinen Gesundheitszustands eines Tumorpatienten |
CN115120681A (zh) * | 2022-07-19 | 2022-09-30 | 浙江长三角聚农科技开发有限公司 | 竹笋生物炭在制备治疗糖尿病及其并发症药物中的应用 |
CN115137733B (zh) * | 2022-08-24 | 2024-01-02 | 吉林大学 | 熊去氧胆酸在制备mcr-3酶抑制剂中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4377595A (en) * | 1979-08-13 | 1983-03-22 | Massachusetts Institute Of Technology | Process for reducing depression |
US4898879A (en) * | 1981-06-29 | 1990-02-06 | Baxter International Inc. | Nurtitional composition for management of hepatic failure |
US5087453A (en) * | 1990-11-01 | 1992-02-11 | Otsuka Pharmaceutical Co., Ltd. | Method for the treatment of bacterial caused weight loss and/or hypoglycemia |
US5674855A (en) * | 1992-08-12 | 1997-10-07 | The Rogosin Institute | Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
US5589358A (en) * | 1993-12-29 | 1996-12-31 | Univ Wake Forest | Ileal bile acid transporter compositions and methods |
IT1274000B (it) * | 1994-04-06 | 1997-07-14 | Alfa Wassermann Spa | Derivati di acidi biliari utili nella terapia della calcolosi biliare da colesterolo e nelle patologie indotte da colestasi |
US5763435A (en) * | 1995-11-21 | 1998-06-09 | Children's Hospital Medical Center | Sulfate conjugates of ursodeoxycholic acid, and their beneficial use in inflammatory disorders |
US5998386A (en) * | 1997-09-19 | 1999-12-07 | Feldman; Arthur M. | Pharmaceutical compositions and method of using same for the treatment of failing myocardial tissue |
-
2000
- 2000-03-09 EP EP00920504A patent/EP1212064A2/de not_active Withdrawn
- 2000-03-09 WO PCT/EP2000/002062 patent/WO2000053165A2/en active IP Right Grant
- 2000-03-09 AT AT00916915T patent/ATE365043T1/de not_active IP Right Cessation
- 2000-03-09 AU AU41056/00A patent/AU4105600A/en not_active Abandoned
- 2000-03-09 ES ES00916915T patent/ES2288847T3/es not_active Expired - Lifetime
- 2000-03-09 AU AU38099/00A patent/AU3809900A/en not_active Abandoned
- 2000-03-09 DE DE60035262T patent/DE60035262T2/de not_active Expired - Fee Related
- 2000-03-09 DK DK00916915T patent/DK1158989T3/da active
- 2000-03-09 WO PCT/EP2000/002299 patent/WO2000053224A2/en active Application Filing
- 2000-03-09 PT PT00916915T patent/PT1158989E/pt unknown
- 2000-03-09 EP EP00916915A patent/EP1158989B1/de not_active Expired - Lifetime
-
2007
- 2007-01-25 US US11/627,183 patent/US20070197485A1/en not_active Abandoned
- 2007-09-14 CY CY20071101218T patent/CY1107436T1/el unknown
-
2008
- 2008-08-06 US US12/187,169 patent/US20090197851A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60035262T2 (de) | 2008-02-21 |
ES2288847T3 (es) | 2008-02-01 |
WO2000053165A2 (en) | 2000-09-14 |
WO2000053165A3 (en) | 2001-04-12 |
US20070197485A1 (en) | 2007-08-23 |
AU4105600A (en) | 2000-09-28 |
DK1158989T3 (da) | 2007-10-22 |
DE60035262D1 (de) | 2007-08-02 |
AU3809900A (en) | 2000-09-28 |
PT1158989E (pt) | 2007-10-01 |
US20090197851A1 (en) | 2009-08-06 |
WO2000053224A3 (en) | 2002-04-04 |
CY1107436T1 (el) | 2012-12-19 |
WO2000053224A2 (en) | 2000-09-14 |
EP1158989A2 (de) | 2001-12-05 |
EP1158989B1 (de) | 2007-06-20 |
EP1212064A2 (de) | 2002-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107436T1 (el) | Χρηση των αναστολεων της ενδοτοξινης για την θεραπεια της καχεξιας | |
Wersall et al. | Ototoxicity of gentamicin | |
Stenvinkel | Inflammatory and atherosclerotic interactions in the depleted uremic patient | |
CN102791262A (zh) | 用于处理生物薄膜的d-氨基酸 | |
ATE247974T1 (de) | Kombinationtherapie mit einem tnf-bindendem protein zür behandlung von durch tnf verursachten erkrangungen | |
RU95106651A (ru) | Аналоги дзе-тур динорфина и способ лечения толерантных состояний у пациента | |
DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
NO170114B (no) | Elektrisk kontaktklemme | |
Scott et al. | Adjuvant activity of saponin: antigen localization studies | |
ATE481111T1 (de) | Pax2 zur behandlung von nierenkrankheiten | |
RU95112534A (ru) | Дерматансульфаты и их соли, противотромбозные средства, способ предупреждения или лечения тромбозов, способ предупреждения или лечения синдрома рассеянной интраваскулярной коагуляции, способ лечения инфаркта миокарда | |
DE69733557D1 (de) | Endothelin-antagonisten zur behandlung von herzversagen | |
Trooskin et al. | Failure of demonstrated clinical efficacy of antibiotic-bonded continuous ambulatory peritoneal dialysis (CAPD) catheters | |
Nagao et al. | Immunotherapy for the treatment of acute paraquat poisoning | |
AU609909B2 (en) | Urease antigen product & process | |
Jivegård et al. | The effects of morphine and enkephaline on gallbladder function in experimental cholecystitis: Inhibition of inflammatory gallbladder secretion | |
US6753341B1 (en) | Inhibition of PKC to treat permability failure | |
Neild et al. | Severe systemic vascular necrosis in cyclosporin-treated rabbits with acute serum sickness. | |
Bennett et al. | Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats | |
CA2468496A1 (en) | Ilk inhibitors for the treatment of renal disease | |
ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
Strauss et al. | Effect of Sulfated β-cyclodextrin, a Water Soluble Cycloamylose, on the Promotion and/or Inhibition of Angiogenesis | |
Nowotny et al. | Studies on host defenses enhanced by endotoxins: a brief review | |
EP0790250A3 (de) | Inhibitoren des biogenen Amin Transportes | |
El Munshid et al. | Importance of the kidneys for gastrin elimination and gastric function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1158989 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |